Skip to main content

George M Shaw

NIH Rank #692
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1969914Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$6.7M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#692
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for George M Shaw. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing George M Shaw as a PI. Multi-PI records show the full award amount for context.

  • 4R33AI161818-05R33
    Combining germline-targeting, B cell immunofocusing and Env-Ab coevolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies
    $1.6M
    award amount
  • 5R01AI167716-04R01
    B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution
    $960.4K
    award amount
  • 5P01AI131251-08P01
    SHIV Env-antibody coevolution as a molecular guide to HIV-1 V3 glycan targeted vaccine design
    $885.5K
    award amount
  • 1R01AI183332-01R01
    SHIV-guided design of novel HIV-1 fusion peptide immunogens
    $807.6K
    award amount
  • 5R01AI165080-04R01
    HIV-1 Q23.17 Env: Engineering a novel immunogen to elicit broadly neutralizing antibodies
    $804.3K
    award amount
  • 5R01AI160607-04R01
    Reverse Vaccinology in SHIV Infected Macaques as a Molecular Guide for HIV-1 Vaccine Design
    $804.3K
    award amount
  • 3R01AI165080-04S1R01
    HIV-1 Q23.17 Env: Engineering a novel immunogen to elicit broadly neutralizing antibodies
    $795.1K
    award amount

Award organization

Organizations that administered FY2024 awards listing George M Shaw as a PI.

FY2024 award administered by University of Pennsylvania (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Pennsylvania
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #692
  7. 2024
    Entered Top 25% Nationally
    Ranked #692
  8. 2024
    Entered Top 10% Nationally
    Ranked #692
  9. 2024
    Entered Top 5% Nationally
    Ranked #692
  10. 2025
    $10M Cumulative Funding
  11. 2025
    R01 Grant Holder
  12. 2025
    Program/Center Grant Leader